Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bio-Products outperforms the whole at Kyowa Hakko

This article was originally published in Clinica

Executive Summary

Kyowa Hakko (Japan) has reported a 9.5% sales increase in 1994 by its Pharmaceuticals and Bio-Products Division, which includes diagnostic reagents subsidiary Kyowa Medex. Turnover was ¥74,967 million ($2,083 million) compared with Yen158,892 million in 1993. Divisional operating income was up 26.3% at Yen28,730 million. Group turnover rose 5.7% to Yen341,545 million with net profits up 69% at Yen10,646 million.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT091768

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel